St. Jude Medical announces acquisition of CardioMEMS and FDA approval of the CardioMEMS HF System

 

St. Jude Medical acquires CardioMEMS and announces FDA approval
of heart failure (HF) monitoring technology

The acquisition of CardioMEMS, a medical device company that developed a miniaturized, wireless monitoring sensor to directly measure PA pressure, further strengthens the St. Jude Medical industry-leading HF product line and positions the company to establish itself as the leader in providing HF disease management solutions.

Read the News Release
 
 

The CardioMEMS™ HF System

CardioMEMS™ HF System

St. Jude Medical is proud to introduce a new tool for comprehensive heart failure care. The CardioMEMS™ HF System is the first and only FDA-approved heart failure (HF) monitor proven to significantly reduce HF hospital admissions and improve quality of life in NYHA class III patients.

When used by clinicians to manage HF, the CardioMEMS HF System is:

  • Safe and reliable – 98.6% of patients were free from device or system complications1
  • Clinically proven – reduced HF admissions by 37%1
  • Proactive and personalized – patient management through direct monitoring of PA pressure and titration of medications

 

About St. Jude Medical

St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world’s most expensive, epidemic diseases. The company does this by developing cost-effective medical technologies that save and improve lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical has four major clinical focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation.